Acute haemodynamic effects of nicorandil in patients with chronic severe regurgitant valvular lesions

Indian Heart Journal

Volumn 50, Issue 2, 1998, Pages 173-178

  Yadav, R ^a   Bhargava, B ^a   Aggarwal, R ^a   Narang, R ^a   Chopra, A ^a   Sapra, R ^a   Manchanda, S C ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

NICORANDIL; POTASSIUM CHANNEL;

ADOLESCENT; ADULT; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; FEMALE; HEART INDEX; HEART OUTPUT; HEMODYNAMIC PARAMETERS; HUMAN; LUNG CAPILLARY PRESSURE; MALE; MITRAL VALVE REGURGITATION; PULMONARY ARTERY; VASCULAR RESISTANCE;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AORTIC VALVE INSUFFICIENCY; CHRONIC DISEASE; FEMALE; FOLLOW-UP STUDIES; HEMODYNAMIC PROCESSES; HUMANS; MALE; MITRAL VALVE INSUFFICIENCY; NIACINAMIDE; NICORANDIL; POTASSIUM CHANNELS; RHEUMATIC HEART DISEASE; TREATMENT OUTCOME; VASODILATOR AGENTS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0031746619     PISSN: 00194832     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Kinoshita M, Sakai K. Pharmacology and therapeutic effects of nicorandil. Cardiovasc Drugs Ther 1990; 4: 1075-1088
2. Taira N. Nicorandil as a hybrid between nitrates and potassium channel activators. Am J Cardiol 1989; 63: 18J-24J
3. Taira N. Similarity and dissimilarity in the mode and mechanisms of action between nicorandil and classical nitrates: An overview. J Cardiovasc Pharmacol 1987; 10 (Suppl. 8): S1-S9
4. Kato K, Asanoi H, Wakabayashi C, Hosoda S, Shiina A. Effect of nicorandil on exercise performance in patients with effort angina - A multicenter trial using a treadmill exercise test. J Cardiovasc Pharmacol 1987; 10 (Suppl. 8): S98-S103
5. Kinoshita M, Hashimoto K, Ohbatashi Y, Inoue T, Taguchi H, et al. Comparison of antianginal activity of nicorandil, propranolol and diltiazem with reference to the antianginal mechanism. Am J Cardiol 1989; 63: 71J-74J
6. Aizawa T, Ogasawara K, Nakamura F, Hirosaka A, et al. Effect of nicorandil on coronary spasm. Am J Cardiol 1989; 63: 75J-79J
7. Meany TB, Richardson P, Cammn J, Coltart J, Griffith M, et al. Exercise capacity after single and twice daily dose of nicorandil m chronic stable angina. Am J Cardiol 1989; 63 (Suppl): 66J-70J
8. Ulvenstam G, Diderhoim E, Frithz G, Gudbrandsson T, Hedback B, et al. Antianginal and antiischemic efficacy of nicorandil compared with nefedipine in patients with angina pectoris and coronary heart disease. A Pharmacol 1992; 20 (Suppl 3): S67-S73
9. Di Somma S, Liquori V, Verdecchia P, Porcellati P, Bertocchi F, et al. A double blind comparison of nicorandil and metaprolol in patients with effort stable angina (Abstract). Eur Heart J 1990; 11(Suppl): 80
10. Belz GG, Matthews JH, Beck A, Wagner G, Schneider B. Hemodynamic effects of nicorandil, isosorbide dinitrate and dihydralazine in healthy volunteers. J Cardiovasc Pharmacol 1985; 7: 1107-1112
11. Belz GG, Matthews JH, Heinrich J, Wagner G. Controlled comparison of the pharmacodynamic effect of nicorandil (SG-75) and isosorbide dinitrate in man. Eur J Clin Pharmacol 1984; 26: 681-685
12. Holzmann S, Kukovetz WR, Braida C, Poch G. Molecular mechanism of action of nicorandil. Eur J Pharmacol 1992; 215: 1-7
13. Gross GJ, Pieper G, Farber NE, Warltier D, Hardman H. Effects of nicorandil as coronary circulation and myocardial ischemia. Am J Cardiol 1989; 63: 11J-17J
14. Fenici RR, Melillo G. Effects of nicorandil on human cardiac electrophysiology parameters (Abstract). Cardiovasc Drugs Ther 1991; 5(Suppl. 3): 367
15. Wagner G. Selected issues from an overview on nicorandil: Tolerance, duration of action and long term efficacy. J Cardiovasc Pharmacol 1992; 20 (Suppl): 28-33
16. Flaherty JT. Nitrate tolerance: A review of the evidence. Drugs 1989; 37: 523-550
17. Silke B, Verma SP, Ali MS, Goldhammer E, Taylor SH, et al. Effects of nicorandil on left ventricle hemodynamics and volume at rest and during exercise-induced angina. Am J Cardiol 1989; 63: 49J-55J
18. Murakami M, Takeyama Y, Matsubara H, Hasegawa S, Nakamura N, et al. Effects of intravenous injection of nicorandil on systemic and coronary haemodynamics in patients with old myocardial infarction (Abstract). Eur Heart J 1989; 10 (Suppl): 426
19. Yokota M, Horisawa T, Iware M, Miyahara T, Yoshida Y, et al. Effect of new vasodilator, nicorandil on exercise induced impairment of left ventricle function in patients with old myocardial infarction. J Cardiovasc Pharmacol 1987; 10 (Suppl. 8): S116-S120
20. Quiroz AC, Giles TD, Roffidal L, Sander GE, Haney Y, et al. Intravenous nicorandil in CHF (Abstract). Clin Res 1990; 38: 4A
21. Bolen JL, Alderman EL. Hemodynamic consequences of afterload reduction in patients with chronic aortic regurgitation. Circulation 1976; 53: 879-883
22. Miller RR, Vismara LA, DeMaria AN, Salel AF, Mason DT. Afterload reduction therapy with nitroprusside in severe AR: Improved cardiac performance and reduced regurgitant volume. Am J Cardiol 1976; 38: 564-567
23. Greenberg BH, Demots H, Murphy E, Rahimtoola S. Mechanism of improved cardiac performance with arteriolar dilators in aortic insufficiancy. Circulation 1981; 63: 263-268
24. Rothlisberger C, Sareli P, Wisenbaugh T. Comparison of single dose nifedipine and captropril for severe chronic aortic regurgitation. Am J Cardiol 1993; 72: 799-804
25. Fioretti P, Benussi B, Scardi S, Klugmann S, Brower RW, Camerini F. Afterload reduction with nifedipine in aortic insufficiency Am J Cardiol 1982; 49: 1728-1732
26. Goodman DJ, Rossen RM, Holloway EL, Alderman EL, Harrison DC. Effect of nitroprusside on left ventricular dynamics in mitral regurgitation. Circulation 1974; 50: 1025-1032
27. Debary P, Kaudelkora E, Henzloram M. Haemodynamic effect of prazocin in patients of chronic aortic regurgitation. Am Heart J 1983; 105: 567-574
28. Chatterjee K, Parmley WW, Swan HJC, Berman G, Forrester J, Marcus HS. Beneficial effect of vasodilator agents in severe mitral regurgitation due to dysfunction of subvalvular apparatus. Circulation 1973; 48: 684-690
29. Harshaw CW, Grossman W, Munro AB, McLaurin LP. Reduced systemic vascular resistance as therapy for severe mitral regurgitation of valvular origin. Ann Intern Med 1975; 83: 312-316
30. Greenberg BH, Massie BM, Brundage BM, Batvinick EH, Parmley WW, Chatterjee K. Beneficial effects of hydralazine in severe mitral regurgitation. Circulation 1978; 58: 273-279
31. Rothlisberger C, Sareli P, Wisenbaugh T. Comparison of single dose nifedipine and captopril for chronic severe mitral regurgitation. Am J Cardiol 1994; 73: 978-981
32. Elkayam V, Roth A, Kumar A, Kulick D, McIntosh N, McKay CR, Rahimtoola SH. Hemodynamic and volumetric effects of venodilation with nitroglycerins in chronic mitral regurgitation. Am J Cardiol 1987; 60: 1106-1111
33. Jeang MK, Petrovich LJ, Adyanthaya AV, Alexander JK. Effects of isosorbide dinitrate on rheumatic and non-rheumatic mitral regurgitation. Texas Heart Inst J 1986; 13: 453-457
34. Lin M, Chiang HT, Lin SL, et al. Vasodilator therapy in chronic asymptomatic aortic regurgitation, enalapril versus hydralazine therapy. J Am Coll Cardiol 1994; 24: 1046-1053
35. Schon HR, Schroter G, Blomer H, Schomig A. Beneficial effects of a single dose of quinapril on left ventricular performance in chronic mitral regurgitation. Am J Cardiol 1994; 73: 985-991
36. Wisenbaugh T, Essop R, Rothlisberger C, Sareli P. Effects of a single oral dose of captopril on left ventricular performance in severe mitral regurgitation. Am J Cardiol 1992; 69: 348-353
37. Chibana T, Nagamine F, Sunagawa R, Oshiro R, Nakada Y, et al. Comparison of the acute hemodynamic and coronary vasodilating effect between nicorandil & glyceryl trinitrate Arznel mittel Forschung 1991; 41: 591
38. Kobayashi K, Hakuta T. Effects of nicorandil on coronary hemodynamic in ischemic heart disease: Comparison with NTG, nifedipine and propranolol. J Cardiovasc Pharmacol 1987; 10 (Suppl 8): S109-S115
39. Aizawa T, Ogasawara K, Kato K. Effects of nicorandil on coronary circulation in patients with ischemic heart disease: Comparison with nitroglycerin. J Cardiovasc Pharmacol 1987; 10 (Suppl. 8): S123-S129
40. Ohnishi M, Matsuda Y, Shiotani H, Yamabe H, Maeda K, et al. Effects of nicorandil on hemodynamics in congestive heart failure (Abstract). Eur Heart J 1990; 11 (Suppl): 395
41. Yamakado T, Murayama S, Ueda K, Nakano T. Effects of nicorandil: A new antianginal K+ channel opener on left ventricular function in coronary artery disease: Comparison with nitroglycerin and nifedipine (Abstract). J Am Coll Cardiol 1991; 17: 378A
42. Coltart DJ, Signy M. Acute hemodynamic effects of single dose nicorandil in coronary artery disease. Am J Cardiol 1989; 63: 34J-39J
43. Suryapranata H, Serruys PW, DeFeyter PJ, Verdouw PD, et al. Coronary vasodilatory action after a single dose of nicorandil. Am J Cardiology 1988; 61: 292-297